Toggle navigation
Home
Search
Services
Blog
Contact
About
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill
Andrulis Research Corporation, Bethesda, MD, United States
Search 7 grants from Gill Devinder
Search grants from Andrulis Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Research Training in Pulmonary Immunology and Allergy at MGH
Dissemination;User Education Across a Broad Range of Audiences
Social Modification of Primate Behavior
Research in the Pathogenesis of Hematologic Disorders
Act 299 - Recombinant Interleukin 2 in Symptomatic HIV Infected Children
Recently added grants:
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
The impact of obesity on cerebral glucose transport and metabolism
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease (ESRD) Patients with Type 2 Diabetes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057818-000
Application #
3613432
Study Section
Project Start
1985-09-30
Project End
Budget Start
1985-09-30
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Andrulis Research Corporation
Department
Type
DUNS #
City
Bethesda
State
MD
Country
United States
Zip Code
20814
Related projects
NIH 1986
N43 CM
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill / Andrulis Research Corporation
NIH 1985
N43 CM
Polymeric Platinum Complexes as Anicancer Prodrugs
Devinder, Gill / Andrulis Research Corporation
Comments
Be the first to comment on Gill Devinder's grant